King Faisal Specialist Hospital & Research Center (KFSH&RC) Leading the Revolution in Global Healthcare with Artificial Intelligence and Robotics Technology
Saturday, June 29, 2024
King Faisal Specialist Hospital and Research Center (KFSH&RC) is at the forefront of the global AI (Artificial Intelligence) and robotics revolution. The advancements in these technologies, which are being utilized to realize Saudi Vision 2030, are expected to create an economic value of approximately $15-27 billion across the Saudi healthcare sector by 2030. It is also expected to play a pivotal role in streamlining healthcare processes and transforming patient care.
The most notable feature of the technology integration promoted by KFSH&RC is the field of robot-assisted surgery. In 2023 alone, 1,195 robot-assisted surgeries were performed, and in particular, the world’s first liver transplant surgery was performed entirely using robot technology, highlighting KFSH&RC’s leading role in utilizing robot technology to improve surgical precision and patient recovery.
The implementation of whole genome sequencing (WGS) technology, which complements the advancements in surgical techniques, has also become the cornerstone of KFSH&RC for early detection and treatment of genetic diseases. As of 2023, more than 7,000 WGS tests have been performed, enabling the identification of genetic predispositions to various types of diseases. By focusing on cutting-edge surgical techniques and comprehensive genetic analysis, KFSH&RC has created an environment where patients can receive the most accurate and effective treatment benefits at the forefront of medical innovation.
In addition, KFSH&RC's lab is also building an automated system to streamline the diagnostic and testing process. The system has improved accuracy and speed, enabling faster diagnosis and treatment for patients. With over 1.5 million tests processed in this way, processing time has been reduced by 30%.
As KFSH&RC recognized the innovative potential of digital healthcare, it introduced AI-based solutions across multiple departments. With the introduction of AI tools in the field of radiology in 2023, diagnostic accuracy improved by 25% and the misdiagnosis rate decreased by 18%, making progress in the detection and treatment of cancer and cardiovascular disease. By successfully producing CAR-T cells for cancer treatment using artificial intelligence and cutting-edge biotech technology, the company has also had the effect of reducing treatment costs and reducing patient pain.
At the center of the background of the development of KFSH&RC is the Capacity Command Center, which contributed to the optimization of hospital operations and provided the main source of data-based decision-making. The center monitored patient movements to maintain the level of treatment, followed standard procedures, and helped mitigate risks by predicting demand. Launched in September 2021 while pursuing an AI-based strategy, the center has since conducted more than 170,000 intervention procedures, reducing bed waiting times from 32 hours to 6 hours and emergency room waiting times by 14%.
KFSH&RC plans to continue to devote itself to realizing innovation and excellence in medical services as a smart hospital by incorporating cutting-edge technology into the global medical ecosystem.
It is noteworthy that KFSH&RC has been recognized as the most valuable medical brand in Saudi Arabia and the Middle East by ranking first in the Middle East and Africa region and 20th globally for two consecutive years in the 2024 ranking of the world's top 250 academic medical centers announced by Brand Finance. This is the content. In the same year, we achieved the feat of being selected as one of the world's top 250 hospitals by Newsweek Magazine.
For further information, please contact :
Mr. Essam AlZahrani, Acting Head of Media Affairs, 0555254429
Mr. Abdullah Alown, Media Coordination Officer, 0556294232
Source: globenewswire.com